Clinical Trials Rare diseases: how can decentralisation speed up trials and reduce patient burden? 26 Feb 2021
Alector starts Phase I study of AL002 for Alzheimer’s disease Alector has started a Phase I INVOKE clinical study to evaluate AL002 for the treatment... 16th November 2018